Phagelux Announces Acquisition of Novel Delivery Systems

SHANGHAI, December 23, 2014 /PRNewswire/ — Phagelux, Inc., a leading anti-bacterial company developing phage-based solutions, is pleased to announce the acquisition of several biodegradable polymer delivery systems from Iveria Technologies, Inc., a U.S.-based development company specializing in such technologies.

"The acquisition of these technologies from Iveria will allow us to deliver our phage-based antibacterial solutions either as stand-alone products or in combination with more established medicines," said Mark Engel, Chairman of Phagelux. "The latter should open up a series of licensing and co-development opportunities for our company."

About Phagelux, Inc.

Phagelux, Inc. is developing anti-bacterial solutions across multiple fields utilizing various phage and phage-based technologies. Phagelux is headquartered in Shanghai, with laboratories in China and North America.

Media Contact

Dr. Sixiang Zhou
Director of Business Development

To view the original version on PR Newswire, visit:

Leave a Reply